Implicit Bioscience is an unlisted public company based in Brisbane and Seattle. It was founded in 2005 by a number of biopharma veterans including Prof. Peter Andrews AO and Prof. Ian Frazer AC FRS; the company’s mission is to apply groundbreaking immunotherapy to treat serious and life-threatening diseases with few or no effective treatments.
Implicit Bioscience holds worldwide rights to IC14 and is developing it in the new field of immunoneurology for a range of neurodegenerative and neurotraumatic disease indications. IC14 is a biologic monoclonal antibody drug that inactivates CD14 on immune cells and in circulation. CD14 is a master regulator of the immune response that is also a key organiser of responses by the brain’s most common immune cell to infection and injury. Hyper-activated CD14 results in damaging inflammation that kills healthy brain and other cells in diseases such as MND/ALS.
Company Details
- Employees
- 11
- Founded
- 2005
- Address
- 32 Logan Rd, Woolloongabba,queensland 4102,australia
- Phone
- +1 (206) 462 2261
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- implicitbioscience.com
- Keywords
- Biotechnology.
- HQ
- Woolloongabba, Queensland
Implicit Bioscience Questions
Implicit Bioscience's helpline number is +1 (206) 462 2261
Implicit Bioscience's website is implicitbioscience.com
Implicit Bioscience's LinkedIn profile is https://au.linkedin.com/company/implicit-bioscience
Implicit Bioscience has
11 employees.
View email and phone details for 11
employees at Implicit Bioscience.
Implicit Bioscience's industry is
Biotechnology Research
Implicit Bioscience's top competitors are
Alnylam Pharmaceuticals,
Beta Cell Technologies,
Psycheceutical,
Curiosity Crisis Podcast,
Alpine Immune Sciences, Inc.,
Omicinsight,
Adaptive Biotechnologies Corp.,
Avm Biotechnology,
Spinwheel Consulting,
Kainos Medicine, Inc..
Implicit Bioscience's categories are Biotechnology Research
Implicit Bioscience's founding year is 2005
